DI LEO, Alfredo
 Distribuzione geografica
Continente #
NA - Nord America 22.582
AS - Asia 7.807
EU - Europa 7.159
SA - Sud America 1.978
AF - Africa 304
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 39.858
Nazione #
US - Stati Uniti d'America 22.280
SG - Singapore 3.266
IT - Italia 2.032
CN - Cina 1.738
BR - Brasile 1.598
RU - Federazione Russa 1.544
HK - Hong Kong 960
SE - Svezia 883
DE - Germania 714
VN - Vietnam 517
FR - Francia 392
GB - Regno Unito 371
UA - Ucraina 360
FI - Finlandia 355
IN - India 238
BD - Bangladesh 215
AR - Argentina 139
CA - Canada 132
IQ - Iraq 122
ID - Indonesia 121
BE - Belgio 103
TR - Turchia 95
MX - Messico 83
ZA - Sudafrica 78
PL - Polonia 75
CO - Colombia 69
PK - Pakistan 64
ES - Italia 60
JP - Giappone 60
NL - Olanda 55
UZ - Uzbekistan 53
PH - Filippine 52
SA - Arabia Saudita 50
EC - Ecuador 49
CI - Costa d'Avorio 47
IE - Irlanda 43
VE - Venezuela 41
MA - Marocco 40
TN - Tunisia 29
JO - Giordania 28
AT - Austria 27
KE - Kenya 27
CL - Cile 25
MY - Malesia 25
PY - Paraguay 23
RO - Romania 23
CZ - Repubblica Ceca 22
EG - Egitto 22
AE - Emirati Arabi Uniti 20
PE - Perù 19
DZ - Algeria 18
IL - Israele 18
IR - Iran 18
KZ - Kazakistan 18
AL - Albania 17
AZ - Azerbaigian 17
AU - Australia 14
GT - Guatemala 14
LB - Libano 13
NP - Nepal 13
CR - Costa Rica 12
ET - Etiopia 12
JM - Giamaica 12
LT - Lituania 11
TH - Thailandia 10
KR - Corea 9
QA - Qatar 9
BO - Bolivia 8
GR - Grecia 8
OM - Oman 8
PA - Panama 8
PS - Palestinian Territory 8
TW - Taiwan 8
BB - Barbados 7
BG - Bulgaria 7
CH - Svizzera 7
KG - Kirghizistan 7
NI - Nicaragua 7
RS - Serbia 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
EU - Europa 6
HN - Honduras 6
KW - Kuwait 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AO - Angola 5
GA - Gabon 5
GE - Georgia 5
LV - Lettonia 5
MD - Moldavia 5
MK - Macedonia 5
DO - Repubblica Dominicana 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BW - Botswana 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
LU - Lussemburgo 3
Totale 39.808
Città #
Fairfield 2.600
Ashburn 2.084
Woodbridge 1.919
Singapore 1.798
Chandler 1.385
Houston 1.290
Seattle 1.069
San Jose 1.056
Hong Kong 954
Cambridge 904
Ann Arbor 863
Jacksonville 823
Wilmington 822
Milan 767
Nyköping 704
Dallas 616
Beijing 553
New York 389
Lawrence 292
Roxbury 286
Rome 285
Los Angeles 263
Nanjing 254
Lauterbourg 252
Bari 186
Des Moines 177
Council Bluffs 166
Boardman 160
Dearborn 154
Santa Clara 143
Ho Chi Minh City 140
Inglewood 139
São Paulo 138
Helsinki 135
Princeton 126
Brooklyn 118
Columbus 118
Hanoi 109
Brussels 103
Munich 99
Buffalo 91
San Diego 90
Chicago 79
Atlanta 75
Jakarta 68
Nanchang 67
Frankfurt am Main 66
Shenyang 65
London 62
Figino 61
Moscow 61
Warsaw 60
Hebei 58
Dong Ket 55
Tokyo 55
Turin 54
Jiaxing 53
Orem 51
Rio de Janeiro 48
Abidjan 47
Johannesburg 47
Tashkent 46
The Dalles 46
Changsha 44
Montreal 44
Dublin 43
Falkenstein 42
Baghdad 41
San Francisco 41
Stockholm 41
Tianjin 41
Belo Horizonte 40
Nuremberg 40
Denver 38
Paris 38
Dhaka 35
Mexico City 34
Pune 34
Chennai 33
Boston 32
Hefei 32
Toronto 32
Haiphong 28
Brasília 27
Curitiba 27
Naples 27
Porto Alegre 27
Amman 26
Manchester 26
Medellín 26
Phoenix 26
Redwood City 26
Da Nang 25
Falls Church 25
Guangzhou 25
Istanbul 25
Mumbai 24
Bologna 23
Lahore 23
Nairobi 23
Totale 27.028
Nome #
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 779
Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study 368
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 304
Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: an easy, reliable and non-invasive procedure 302
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 264
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 231
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome? 222
Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection 220
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 218
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 216
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 214
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 210
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 208
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 208
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 207
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 206
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 204
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients 196
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 196
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 196
Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions 194
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 193
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 191
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 190
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 188
Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation 188
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 186
Anti-viral therapy in chronic HBV infection: a single centre experience. 183
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 175
Serum fructosamine and colorectal adenomas 174
Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial 174
Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study 174
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 174
A mysterious case of gastroparesis: could the secret be found in a drink? 172
Curcumin and colorectal cancer: From basic to clinical evidences 171
Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident? 168
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. 168
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 167
Antagonistic activity of potential probiotic Lactobacilli against the ureolytic pathogen Yersinia enterocolitica 167
Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence 167
Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. 166
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 166
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 166
Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. 165
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 165
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 162
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 161
Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: A pilot study 160
Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture 160
The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. 159
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients 159
Estrogens, phytoestrogens and colorectal neoproliferative lesions 158
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 158
Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1) 157
Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma 157
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 156
Lesson from an intriguing case of cryoglobulinemia 156
Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions 156
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 156
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 155
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 154
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 153
Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice 150
Evaluation of non-celiac gluten sensitivity in patients with previous diagnosis of irritable bowel syndrome: A randomized double-blind placebo-controlled crossover trial 148
H. pylori status and angiogenesis factors in human gastric carcinoma 147
Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a) 147
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 147
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy 146
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 146
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 145
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. 144
Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice 144
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 143
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 143
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma 142
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 142
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 142
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease 141
Celiac disease and common variable immunodeficiency: a familial inheritance? 141
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 141
Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice 140
Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics 137
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 137
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 136
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 136
Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage 135
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. 135
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 134
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 134
The association between cardiac and gastrointestinal disorders: causal or casual link? 133
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 133
Survival after the diagnosis of de novo malignancy in liver transplant recipients 133
Estrogen receptor beta as target for colorectal cancer prevention 132
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 131
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation 131
Circadian rhythm of hepatic cytosolic and nuclear estrogen receptors. 130
Improved efficacy of 10-Day sequential treatment for Helicobacter Pylori eradication in children: a randomized trial 130
The cost of inflammatory bowel disease management matches with clinical course: A single outpatient centre analysis 130
Lactobacillus reuteri strain combination in helicobacter pylori infection: A randomized, double-blind, placebo-controlled study 129
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori 129
Totale 17.502
Categoria #
all - tutte 160.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.125 127 187 55 99 110 178 82 132 142 157 350 506
2022/20233.490 491 429 243 287 383 491 35 402 553 21 95 60
2023/20241.218 104 229 52 113 91 350 29 39 8 57 15 131
2024/20255.367 125 78 407 135 154 477 638 544 266 300 782 1.461
2025/202613.720 1.752 569 1.054 1.173 1.439 606 1.429 370 2.153 1.168 461 1.546
2026/20271.007 1.007 0 0 0 0 0 0 0 0 0 0 0
Totale 40.957